Amit Arvind Joharapurkar on Muck Rack

Amit Arvind Joharapurkar

As seen in: Wiley Online Library, Diabetes Magazine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Amit Arvind

Contact Amit Arvind, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Recent Development in Celiac Disease: Pathophysiology, Animal Models and Treatments

|
By Vishal Patel, Amit Arvind Joharapurkar, Mukul Jain
| Wiley Online Library
Conflicts of Interest All the authors are employees of Zydus Research Centre, Zydus Lifesciences Limited. The other authors declare no conflicts of interest. References , and . 2014. “IL-15: A Central Regulator of Celiac Disease Immunopathology.” Immunological Reviews 260: 221–234. https://doi.org/10.1111/imr.12191. , , and . 2022. “A Mouse Model of Celiac Disease.” Current Protocols 2: e515. https://doi.org/10.1002/cpz1.515. , , , et al. 2020.
Open in Who Shared Issue with article?

Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease

|
By Vishal Patel, Amit Arvind Joharapurkar, Maulik Patel, Samadhan Kshirsagar
| nrcresearchpress.com
Nonalcoholic fatty liver disease (NAFLD) is often associated with obesity and type 2 diabetes. Coagonists of glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR) are under clinical investigation for the treatment of obesity and type 2 diabetes. In this study, we have demonstrated the effect of a balanced coagonist in the treatment of NAFLD using mouse models.
Open in Who Shared Issue with article?

Erratum. Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced Osteopenia. Diabetes 2015;64:260

|
By Abhishek Kumar Singh , Manisha C. Yadav, Mohd. Parvez Khan, Amit Arvind Joharapurkar
| Diabetes Magazine
Erratum. Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1? and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced Osteopenia. Diabetes 2015;64:2609–2623 Mohd.
Open in Who Shared Issue with article?
See all 3 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Amit Arvind

Contact Amit Arvind, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified